GlassScriptPhysician profile
Hylton Ivan Lightman
NPI 1043375728
$1,879.19
in general payments reported to CMS, 2019-2025
17 companies · $71.81 in 2025
The $71.81 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $622 · 2020: $198 · 2021: $452 · 2022: $194 · 2023: $206 · 2024: $135 · 2025: $71.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $427.86 | 2019-2024 | Bexsero |
| Abbvie INC. | $310.94 | 2019-2021 | |
| Corium, LLC | $224.15 | 2022-2025 | Azstarys |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $208.88 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $187.21 | 2021-2025 | Vpriv |
| Merck Sharp & Dohme LLC | $143.65 | 2019-2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Pfizer INC. | $102.09 | 2019-2023 | |
| Sanofi Pasteur INC. | $55.05 | 2022-2024 | |
| Supernus Pharmaceuticals, INC. | $48.56 | 2021-2023 | Qelbree |
| Shire North American Group INC | $39.83 | 2019 | |
| Cranial Technologies, INC | $33.29 | 2021-2023 | Doc Band |
| Seqirus USA INC | $18.90 | 2022 | |
| Sobi, INC | $17.00 | 2019 | |
| Phadia US INC. | $16.75 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $15.83 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15.00 | 2021 | |
| Genentech USA, INC. | $14.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hylton Lightman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.